Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到34条与MPL有关的结果

Cervical Cancer Screening in Poland in Current SARS-CoV-2 Pandemic: Interim Guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a Summary January 2021

2021年发布于 Ginekologia polska 92卷第2期 所属人体系统：生殖 | 子宫肿瘤

Polish Society of Gynecologists and Obstetricians Polish Society of Colposcopy and Cervical Pathophysiology

HPV Testing SARS-CoV-2 Pandemic Abnormal Screening Results Cervical Cancer Prevention Cervical Cytology Guidelines Selfsampling
指南简介 原文链接
Consensus Statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS) on Pediatric Benign and Malignant Thyroid Surgery

2021年发布于 Head Neck 43卷第4期 所属人体系统：内分泌 | 甲状腺肿瘤

American Association of Clinical Endocrinology American Head and Neck Society Endocrine Surgery Section

Complications Differentiated Diffuse Sclerosing Variant Hypoparathyroidism Laryngeal Nerve Monitoring Neck Dissection Pediatric Surgery Surgical Outcomes Thyroid Cancer.
指南简介 原文链接
Nursing Procedures for the Prevention and Treatment of Mucositis Induced by Cancer Therapies: Clinical Practice Guideline Based on an Interdisciplinary Consensus Process and a Systematic Literature Search

2021年发布于 Integrative Cancer Therapies 20卷第期 所属人体系统：其他 | 症状管理

无

Chemotherapy Complementary Integrative Medicine Mucositis Naturopathic Radiotherapy Side Effects Stomatitis
指南简介 原文链接
Neurological and Vascular Complications of Primary and Secondary Brain Tumours: EANO-ESMO Clinical Practice Guidelines for Prophylaxis, Diagnosis, Treatment and Follow-up

2021年发布于 Ann Oncol 32卷第2期 所属人体系统：其他 | 症状管理

European Association of Neuro-Oncology European Society for Medical Oncology

Brain Metastasis Brain Tumour Complications Oedema Seizures Thrombosis
指南简介 原文链接
Developing a Consensus Definition of Psychosocial Complexity in Cancer Patients Using Delphi Methods

2021年发布于 Palliative & Supportive Care 19卷第1期 所属人体系统：其他 | 心理健康

无

Cancer Delphi Oncology Psychosocial Complexity Psyhcooncology Spirituality.
指南简介 原文链接
Chinese Expert Consensus Workshop Report: Guideline for Permanent Iodine-125 Seeds Implantation of Primary and Metastatic Lung Tumors (2020 Edition)

2020年发布于 Journal of Cancer Research and Therapeutics 16卷第7期 所属人体系统：呼吸 | 肺癌

Interstitial Brachytherapy Society Committee of Minimally Invasive Therapy in Oncology Chinese Anti-Cancer Association

Guidelines Implantation Iodine-125 Lung Malignancy.
指南简介 原文链接
Possible Deferral of Diagnostic and Therapeutic Procedures for Patients with Abnormal Screening Tests Results in Cervical Cancer Secondary Prevention in Current SARS-CoV-2 Pandemic Interim Guidelines of the Polish Society of Gynecologists and Obstetrician

2020年发布于 Ginekologia polska 91卷第7期 所属人体系统：生殖 | 子宫肿瘤

Polish Society of Gynecologists and Obstetricians Polish Society of Colposcopy and Cervical Pathophysiology

HPV Testing SARS-CoV-2 Pandemic Abnormal Screening Results Cervical Cancer Prevention Cervical Cytology Guidelines Selfsampling.
指南简介 原文链接
Human Papillomavirus (HPV) Self-sampling as Part of Cervical Cancer Screening

2020年 所属人体系统：生殖 | 子宫肿瘤

World Health Organization

Cervical Cancer HPV sampling screening
指南简介 原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery

2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

Collège National Des Gynécologues Et Obstétriciens Français

Borderline Ovarian Tumour Chirurgie De Clôture Completion Surgery Follow-up Recurrence Risk Factors Relapse Risque De Récidive Récidive Surveillance Tumeur Frontière De L’ovaire.
指南简介 原文链接
Consensus on the Watch and Wait Policy in Rectal Cancer Patients after Neoadjuvant Treatment (2020 Version)

2020年发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷第1期 所属人体系统：消化 | 直肠癌

Chinese Watch & Wait Database Research Cooperation Group Chinese Association of Surgeons Chinese Society of Coloproctology Chinese Medical Doctor Association Chinese Society of Colorectal Surgery Chinese Medical Association Colorectal Cancer Physician Specialty Committee Chinese Medical Doctor Association Radiation Therapy Specialty Committee Chinese Anticancer Association

Clinical Complete Response Neoadjuvant Treatment Rectal Neoplasms Watch and Wait Policy.
指南简介 原文链接
Expert Consensus on Patient Rights Protection When Applying Watch and Wait Strategy after Neoadjuvant Therapy for Rectal Cancer

2020年发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷第3期 所属人体系统：消化 | 直肠癌

Chinese Watch and Wait Database Research Group Chinese College of Surgeons Chinese Medical Doctor Association China Health Law Society Chinese Society of Coloproctology Chinese Medical Doctor Association Chinese Association for Radiation Oncologists Chinese Medical Doctor Association Beijing Health Law Society Medical Law Committee & Patient Safety Committee

Clinical Complete Response Neoadjuvant Therapy Patient Protection Rectal Neoplasms Watch and Wait Strategy.
指南简介 原文链接
UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on Behalf of the Medicines and Healthcare Products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory G

2020年发布于 British Journal of haematology 192卷第3期 所属人体系统：循环 | 淋巴瘤

The Medicines and Healthcare Products Regulatory Agency Plastic Reconstructive and Aesthetic Surgery Expert Advisory Group

BIA‐ALCL reconstructive Breast Surgery Lymphoma breast Implants treatment Guidelines
指南简介 原文链接
Clinical Practice Guidelines for Precision Diagnosis and Treatment of Complex Liver Tumor Guided by Three-dimensional Visualization Technology (version 2019)

2020年发布于 Nan Fang Yi Ke Da Xue Xue Bao 40卷第3期 所属人体系统：消化 | 肝肿瘤

Chinese Society of Digital Medicine Chinese Research Hospital Association of Digital Surgery Committee

Complex Liver Tumors Fluorescence Imaging Hepatectomy Three-dimensional Printing Three-dimensional Visualization Virtual Reality.
指南简介 原文链接
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma

2020年发布于 J Clin Oncol 38卷第10期 所属人体系统：循环 | 淋巴瘤

无

Breast Implant Anaplastic Large-cell Lymphoma Pathologic Diagnosis Guideline
指南简介 原文链接
Chinese Expert Consensus Workshop Report: Guideline for Permanent Iodine-125 Seed Implantation of Primary and Metastatic Lung Tumors

2019年发布于 Thoracic Cancer 10卷第2期 所属人体系统：呼吸 | 肺癌

Chinese Anti-Cancer Association

Guideline Implantation Iodine-125 Lung Malignancy.
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 输卵管癌

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancers (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete 6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended Or a Discussion with the Patient About Intraperitoneal Chemotherapy According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 输卵管癌

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancer (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 卵巢肿瘤

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancers (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete 6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended Or a Discussion with the Patient About Intraperitoneal Chemotherapy According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介 原文链接

人体系统

共搜索到34条 与MPL有关的结果

2021年 发布于 Ginekologia polska 92卷 第2期 所属人体系统： 生殖 | 子宫肿瘤

Polish Society of Gynecologists and Obstetricians Polish Society of Colposcopy and Cervical Pathophysiology

2021年 发布于 Head Neck 43卷 第4期 所属人体系统： 内分泌 | 甲状腺肿瘤

American Association of Clinical Endocrinology American Head and Neck Society Endocrine Surgery Section

2021年 发布于 Integrative Cancer Therapies 20卷 第期 所属人体系统： 其他 | 症状管理

无

2021年 发布于 Ann Oncol 32卷 第2期 所属人体系统： 其他 | 症状管理

European Association of Neuro-Oncology European Society for Medical Oncology

2021年 发布于 Palliative & Supportive Care 19卷 第1期 所属人体系统： 其他 | 心理健康

无

2020年 发布于 Journal of Cancer Research and Therapeutics 16卷 第7期 所属人体系统： 呼吸 | 肺癌

Interstitial Brachytherapy Society Committee of Minimally Invasive Therapy in Oncology Chinese Anti-Cancer Association

2020年 发布于 Ginekologia polska 91卷 第7期 所属人体系统： 生殖 | 子宫肿瘤

Polish Society of Gynecologists and Obstetricians Polish Society of Colposcopy and Cervical Pathophysiology

2020年 所属人体系统： 生殖 | 子宫肿瘤

World Health Organization

2020年 发布于 Gynecol Obstet Fertil Senol 48卷 第3期 所属人体系统： 生殖 | 卵巢肿瘤

Collège National Des Gynécologues Et Obstétriciens Français

2020年 发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷 第1期 所属人体系统： 消化 | 直肠癌

2020年 发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷 第3期 所属人体系统： 消化 | 直肠癌

2020年 发布于 British Journal of haematology 192卷 第3期 所属人体系统： 循环 | 淋巴瘤

The Medicines and Healthcare Products Regulatory Agency Plastic Reconstructive and Aesthetic Surgery Expert Advisory Group

2020年 发布于 Nan Fang Yi Ke Da Xue Xue Bao 40卷 第3期 所属人体系统： 消化 | 肝肿瘤

Chinese Society of Digital Medicine Chinese Research Hospital Association of Digital Surgery Committee

2020年 发布于 J Clin Oncol 38卷 第10期 所属人体系统： 循环 | 淋巴瘤

无

2019年 发布于 Thoracic Cancer 10卷 第2期 所属人体系统： 呼吸 | 肺癌

Chinese Anti-Cancer Association

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Eur J Obstet Gynecol Reprod Biol 236卷 第_期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷 第6期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

2019年 发布于 Eur J Obstet Gynecol Reprod Biol 236卷 第_期 所属人体系统： 生殖 | 卵巢肿瘤

共搜索到34条与MPL有关的结果

2021年发布于 Ginekologia polska 92卷第2期 所属人体系统：生殖 | 子宫肿瘤

2021年发布于 Head Neck 43卷第4期 所属人体系统：内分泌 | 甲状腺肿瘤

2021年发布于 Integrative Cancer Therapies 20卷第期 所属人体系统：其他 | 症状管理

2021年发布于 Ann Oncol 32卷第2期 所属人体系统：其他 | 症状管理

2021年发布于 Palliative & Supportive Care 19卷第1期 所属人体系统：其他 | 心理健康

2020年发布于 Journal of Cancer Research and Therapeutics 16卷第7期 所属人体系统：呼吸 | 肺癌

2020年发布于 Ginekologia polska 91卷第7期 所属人体系统：生殖 | 子宫肿瘤

2020年 所属人体系统：生殖 | 子宫肿瘤

2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷第1期 所属人体系统：消化 | 直肠癌

2020年发布于 Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 23卷第3期 所属人体系统：消化 | 直肠癌

2020年发布于 British Journal of haematology 192卷第3期 所属人体系统：循环 | 淋巴瘤

2020年发布于 Nan Fang Yi Ke Da Xue Xue Bao 40卷第3期 所属人体系统：消化 | 肝肿瘤

2020年发布于 J Clin Oncol 38卷第10期 所属人体系统：循环 | 淋巴瘤

2019年发布于 Thoracic Cancer 10卷第2期 所属人体系统：呼吸 | 肺癌

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 卵巢肿瘤